(Q51803475)
Statements
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study (English)
Martin Sebastian
Philipp Kiewe
Daniel Brust
Christian Peschel
Folker Schneller
Karl-Heinz Rühle
Georg Nilius
Ralf Ewert
Sven Lodziewski
Bernward Passlick
Wulf Sienel
Rainer Wiewrodt
Michael Jäger
Horst Lindhofer
Hilke Friccius-Quecke
Alexander Schmittel